News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
109,417 Results
Type
Article (2659)
Company Profile (24)
Press Release (106734)
Section
Business (43549)
Career Advice (72)
Deals (6806)
Drug Delivery (4)
Drug Development (12598)
Employer Resources (9)
FDA (2200)
Job Trends (2297)
News (62837)
Policy (3646)
Tag
Academia (226)
Accelerated approval (5)
Allergies (29)
Alliances (4875)
ALS (18)
Alzheimer's disease (241)
Antibody-drug conjugate (ADC) (57)
Approvals (2333)
Artificial intelligence (44)
Autoimmune disease (20)
Automation (3)
Bankruptcy (29)
Best Places to Work (2178)
Biosimilars (25)
Biotechnology (17)
Bladder cancer (61)
Brain cancer (5)
Breast cancer (159)
Cancer (967)
Cardiovascular disease (71)
Career advice (67)
Career pathing (4)
CAR-T (41)
Cell therapy (103)
Cervical cancer (7)
Clinical research (11619)
Collaboration (156)
Compensation (120)
Complete response letters (4)
COVID-19 (214)
CRISPR (8)
C-suite (39)
Cystic fibrosis (11)
Data (1321)
Denatured (1)
Depression (13)
Diabetes (61)
Diagnostics (1175)
Digital health (4)
Diversity (1)
Drug discovery (13)
Drug pricing (5)
Drug shortages (5)
Duchenne muscular dystrophy (24)
Earnings (36695)
Employer branding (1)
Employer resources (7)
Events (15210)
Executive appointments (53)
FDA (2855)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (6)
Funding (150)
Gene editing (19)
Generative AI (5)
Gene therapy (58)
GLP-1 (118)
Government (353)
Grass and pollen (1)
Guidances (274)
Healthcare (3020)
HIV (10)
Huntington's disease (5)
IgA nephropathy (21)
Immunology and inflammation (44)
Immuno-oncology (7)
Indications (20)
Infectious disease (236)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (32)
Interviews (7)
IPO (4916)
IRA (2)
Job creations (264)
Job search strategy (58)
Kidney cancer (3)
Labor market (13)
Layoffs (50)
Legal (618)
Liver cancer (16)
Longevity (1)
Lung cancer (135)
Lymphoma (105)
Machine learning (3)
Management (2)
Manufacturing (67)
MASH (45)
Medical device (2696)
Medtech (2704)
Mergers & acquisitions (2040)
Metabolic disorders (181)
Multiple sclerosis (41)
NASH (6)
Neurodegenerative disease (42)
Neuropsychiatric disorders (11)
Neuroscience (429)
NextGen: Class of 2025 (779)
Non-profit (410)
Now hiring (1)
Obesity (69)
Opinion (15)
Ovarian cancer (47)
Pain (25)
Pancreatic cancer (37)
Parkinson's disease (42)
Partnered (4)
Patents (49)
Patient recruitment (28)
Peanut (12)
People (4414)
Pharmaceutical (10)
Pharmacy benefit managers (6)
Phase I (3108)
Phase II (4828)
Phase III (4564)
Pipeline (1554)
Policy (6)
Postmarket research (359)
Preclinical (1059)
Press Release (1)
Prostate cancer (48)
Radiopharmaceuticals (33)
Rare diseases (81)
Real estate (409)
Recruiting (6)
Regulatory (3199)
Reports (13)
Research institute (233)
Resumes & cover letters (8)
Rett syndrome (6)
RSV (7)
Schizophrenia (30)
Series A (24)
Series B (11)
Service/supplier (1)
Sickle cell disease (12)
Special edition (3)
Spinal muscular atrophy (34)
Sponsored (4)
Startups (294)
Stomach cancer (2)
Supply chain (10)
Tariffs (4)
The Weekly (3)
Vaccines (93)
Venture capital (8)
Weight loss (48)
Women's health (10)
Worklife (2)
Date
Today (18)
Last 7 days (81)
Last 30 days (374)
Last 365 days (6382)
2025 (6279)
2024 (7063)
2023 (8291)
2022 (10050)
2021 (11405)
2020 (10139)
2019 (7112)
2018 (5614)
2017 (5399)
2016 (4008)
2015 (5325)
2014 (3659)
2013 (2217)
2012 (2442)
2011 (3011)
2010 (2549)
Location
Africa (81)
Alabama (7)
Alaska (2)
Arizona (50)
Arkansas (1)
Asia (5263)
Australia (1388)
California (2189)
Canada (735)
China (162)
Colorado (81)
Connecticut (88)
Delaware (83)
Europe (15372)
Florida (282)
Georgia (67)
Idaho (5)
Illinois (125)
India (6)
Indiana (131)
Iowa (2)
Japan (99)
Kansas (20)
Kentucky (5)
Louisiana (11)
Maine (43)
Maryland (267)
Massachusetts (1379)
Michigan (56)
Minnesota (162)
Missouri (20)
Montana (4)
Nebraska (1)
Nevada (29)
New Hampshire (13)
New Jersey (627)
New York (608)
North Carolina (206)
North Dakota (2)
Northern California (1151)
Ohio (45)
Oklahoma (2)
Oregon (1)
Pennsylvania (512)
Puerto Rico (10)
Rhode Island (1)
South America (147)
South Carolina (3)
Southern California (846)
Tennessee (26)
Texas (239)
United States (7455)
Utah (57)
Virginia (33)
Washington D.C. (4)
Washington State (165)
Wisconsin (13)
109,417 Results for "41".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World’s First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
December 16, 2025
·
4 min read
Press Releases
AI Proteins Raises $41.5M Series A Financing to Advance De Novo Miniproteins as a New Therapeutic Modality
November 20, 2025
·
3 min read
Press Releases
AHF Commends Gov. Newsom for Signing PBM Reform Bill (SB 41, Weiner)
October 13, 2025
·
1 min read
Press Releases
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial
December 12, 2025
·
3 min read
Press Releases
Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients
October 20, 2025
·
5 min read
Press Releases
Tessera Therapeutics Awarded up to $41.3 Million from ARPA-H to Advance In Vivo CAR-T Therapies
October 9, 2025
·
3 min read
Press Releases
Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress
September 25, 2025
·
5 min read
Press Releases
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
November 6, 2025
·
15 min read
Press Releases
Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
September 25, 2025
·
15 min read
Press Releases
Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK
October 9, 2025
·
3 min read
1 of 10,942
Next
